These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2519329)

  • 1. [Importance of peptide C determination in diabetes].
    Halaby G; Karam J; Jambart S; Aydenian H; Zankoul R; Gannagé MH
    J Med Liban; 1989; 38(1):29-34. PubMed ID: 2519329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus.
    Vlad A; Serban V; Sima A; Timar R; Roşu M
    Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma insulin, C-peptide and glucose concentrations in type I diabetic children after a morning injection of insulin (author's transl)].
    Desjeux JF; Vicq D; Gouedard H; Dieterlen P; Gernez-Lestradet C; Lestradet H
    Arch Fr Pediatr; 1981; 38(6):411-5. PubMed ID: 7027987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
    Gorus FK
    Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical value of C-peptide determination].
    Meier C; Ladewig A; Keller U; Berger W
    Praxis (Bern 1994); 1997 Aug; 86(34):1289-95. PubMed ID: 9381016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes].
    Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical role of the determination of immunoreactive insulin and C-peptide in children with diabetes mellitus].
    Kravets EB
    Pediatriia; 1983 Mar; (3):42-4. PubMed ID: 6346250
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical risk for insulin-dependent diabetes (IDD) in sibs. Further definition of genetic heterogeneity.
    Chern MM; Anderson VE; Barbosa J
    Diabetes; 1982 Dec; 31(12):1115-8. PubMed ID: 6757023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.